Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples